Lower corticosteroid skin blanching response is associated with severe COPD.
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by ongoing inflammatory and remodeling processes of the airways and lung tissue. Inflammation can be targeted by corticosteroids. However, airway inflammation is generally less responsive to steroids i...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3951419?pdf=render |
id |
doaj-497654784fb74750af3b1afc50cefe62 |
---|---|
record_format |
Article |
spelling |
doaj-497654784fb74750af3b1afc50cefe622020-11-25T01:42:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9178810.1371/journal.pone.0091788Lower corticosteroid skin blanching response is associated with severe COPD.Susan J M HoonhorstNick H T ten HackenAdèle T Lo Tam LoiLeo KoendermanJan Willem J LammersEef D TelengaH Marike BoezenMaarten van den BergeDirkje S PostmaChronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by ongoing inflammatory and remodeling processes of the airways and lung tissue. Inflammation can be targeted by corticosteroids. However, airway inflammation is generally less responsive to steroids in COPD than in asthma. The underlying mechanisms are yet unclear. This study aimed to assess whether skin corticosteroid insensitivity is associated with COPD and COPD severity using the corticosteroid skin blanching test.COPD patients GOLD stage I-IV (n = 27, 24, 22, and 16 respectively) and healthy never-smokers and smokers (n = 28 and 56 respectively) were included. Corticosteroid sensitivity was assessed by the corticosteroid skin blanching test. Budesonide was applied in 8 logarithmically increasing concentrations (0-100 μg/ml) on subject's forearm. Assessment of blanching was performed after 7 hours using a 7-point scale (normal skin to intense blanching). All subjects performed spirometry and body plethysmography.Both GOLD III and GOLD IV COPD patients showed significantly lower skin blanching responses than healthy never-smokers and smokers, GOLD I, and GOLD II patients. Their area under the dose-response curve values of the skin blanching response were 586 and 243 vs. 1560, 1154, 1380, and 1309 respectively, p<0.05. Lower FEV1 levels and higher RV/TLC ratios were significantly associated with lower skin blanching responses (p = 0.001 and p = 0.004 respectively). GOLD stage I, II, III and IV patients had similar age and packyears.In this study, severe and very severe COPD patients had lower skin corticosteroid sensitivity than mild and moderate COPD patients and non-COPD controls with comparable age and packyears. Our findings together suggest that the reduced skin blanching response fits with a subgroup of COPD patients that has an early-onset COPD phenotype.http://europepmc.org/articles/PMC3951419?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Susan J M Hoonhorst Nick H T ten Hacken Adèle T Lo Tam Loi Leo Koenderman Jan Willem J Lammers Eef D Telenga H Marike Boezen Maarten van den Berge Dirkje S Postma |
spellingShingle |
Susan J M Hoonhorst Nick H T ten Hacken Adèle T Lo Tam Loi Leo Koenderman Jan Willem J Lammers Eef D Telenga H Marike Boezen Maarten van den Berge Dirkje S Postma Lower corticosteroid skin blanching response is associated with severe COPD. PLoS ONE |
author_facet |
Susan J M Hoonhorst Nick H T ten Hacken Adèle T Lo Tam Loi Leo Koenderman Jan Willem J Lammers Eef D Telenga H Marike Boezen Maarten van den Berge Dirkje S Postma |
author_sort |
Susan J M Hoonhorst |
title |
Lower corticosteroid skin blanching response is associated with severe COPD. |
title_short |
Lower corticosteroid skin blanching response is associated with severe COPD. |
title_full |
Lower corticosteroid skin blanching response is associated with severe COPD. |
title_fullStr |
Lower corticosteroid skin blanching response is associated with severe COPD. |
title_full_unstemmed |
Lower corticosteroid skin blanching response is associated with severe COPD. |
title_sort |
lower corticosteroid skin blanching response is associated with severe copd. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation caused by ongoing inflammatory and remodeling processes of the airways and lung tissue. Inflammation can be targeted by corticosteroids. However, airway inflammation is generally less responsive to steroids in COPD than in asthma. The underlying mechanisms are yet unclear. This study aimed to assess whether skin corticosteroid insensitivity is associated with COPD and COPD severity using the corticosteroid skin blanching test.COPD patients GOLD stage I-IV (n = 27, 24, 22, and 16 respectively) and healthy never-smokers and smokers (n = 28 and 56 respectively) were included. Corticosteroid sensitivity was assessed by the corticosteroid skin blanching test. Budesonide was applied in 8 logarithmically increasing concentrations (0-100 μg/ml) on subject's forearm. Assessment of blanching was performed after 7 hours using a 7-point scale (normal skin to intense blanching). All subjects performed spirometry and body plethysmography.Both GOLD III and GOLD IV COPD patients showed significantly lower skin blanching responses than healthy never-smokers and smokers, GOLD I, and GOLD II patients. Their area under the dose-response curve values of the skin blanching response were 586 and 243 vs. 1560, 1154, 1380, and 1309 respectively, p<0.05. Lower FEV1 levels and higher RV/TLC ratios were significantly associated with lower skin blanching responses (p = 0.001 and p = 0.004 respectively). GOLD stage I, II, III and IV patients had similar age and packyears.In this study, severe and very severe COPD patients had lower skin corticosteroid sensitivity than mild and moderate COPD patients and non-COPD controls with comparable age and packyears. Our findings together suggest that the reduced skin blanching response fits with a subgroup of COPD patients that has an early-onset COPD phenotype. |
url |
http://europepmc.org/articles/PMC3951419?pdf=render |
work_keys_str_mv |
AT susanjmhoonhorst lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT nickhttenhacken lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT adeletlotamloi lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT leokoenderman lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT janwillemjlammers lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT eefdtelenga lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT hmarikeboezen lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT maartenvandenberge lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd AT dirkjespostma lowercorticosteroidskinblanchingresponseisassociatedwithseverecopd |
_version_ |
1725038128700325888 |